Logotipo do repositório
 

Publicação:
Ethopharmacological analysis of the open elevated plus-maze in mice

dc.contributor.authorSorregotti, Tatiani [UNESP]
dc.contributor.authorMendes-Gomes, Joyce [UNESP]
dc.contributor.authorRico, Javier Leonardo [UNESP]
dc.contributor.authorRodgers, Robert John
dc.contributor.authorNunes-de-Souza, Ricardo Luiz [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionFundación Universitaria Konrad Lorenz
dc.contributor.institutionUniversity of Leeds
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.date.accessioned2014-05-27T11:29:34Z
dc.date.available2014-05-27T11:29:34Z
dc.date.issued2013-06-01
dc.description.abstractExposure of rodents to an open elevated plus-maze (oEPM) elicits antinociception and increases plasma corticosterone levels. However, no studies have yet assessed the defensive behaviour repertoire of animals in this modified test. In Experiment 1, factor analysis was employed to characterise the behavioural profile of mice exposed to the oEPM. Experiments 2 and 3 assessed the effects of acute alprazolam (0.5-1.5. mg/kg; diazepam 0.5-1.5. mg/kg), pentylenetetrazole (10.0-30.0. mg/kg), yohimbine (2.0-6.0. mg/kg), mCPP (0.3-3.0. mg/kg), and acute and chronic fluoxetine (10.0-30.0. mg/kg) and imipramine (1.0-15.0. mg/kg) on behaviours identified in Experiment 1. The factor analyses revealed that behaviour in the oEPM can largely (77% total variance) be accounted for in terms of 3 factors: factor 1 ('. depth exploration'; e.g. head-dipping on the arms), factor 2 ('. cautious exploration of arms'; e.g. flatback approach), and factor 3 ('. risk assessment'; stretched attend postures - SAP). Experiments 2 and 3 showed that, over the dose range used, alprazolam selectively attenuated all measures of defensiveness. Similar, though more modest, effects were seen with diazepam. Confirming the intensity of the emotional response to the oEPM (nociceptive, endocrine and behavioural), relatively few significant behavioural changes were seen in response to the anxiogenic compounds tested. Although acute fluoxetine or imipramine treatment failed to modify behaviour in the oEPM, chronic fluoxetine (but not chronic imipramine) attenuated total flat back approach and increased head dipping outside the central square. Together, the results indicate that the oEPM induces behavioural defensive responses that are sensitive to alprazolam and chronic fluoxetine. © 2013 Elsevier B.V.en
dc.description.affiliationLaboratory of Pharmacology School of Pharmaceutical Sciences University of Estadual Paulista, UNESP, Araraquara, SP 14801-902
dc.description.affiliationJoint Graduate Program in Physiological Sciences UFSCar/UNESP, Rod. Washington Luís, Km 235, São Carlos, SP 13565-905
dc.description.affiliationLaboratory of Animal Behavior Fundación Universitaria Konrad Lorenz, Bogotá
dc.description.affiliationBehavioural Neuroscience Laboratory Institute of Psychological Sciences University of Leeds, Leeds, England
dc.description.affiliationInstitute for Neuroscience and Behavior-IneC USP, Ribeirão Preto, SP 14040-901
dc.description.affiliationUnespLaboratory of Pharmacology School of Pharmaceutical Sciences University of Estadual Paulista, UNESP, Araraquara, SP 14801-902
dc.description.affiliationUnespJoint Graduate Program in Physiological Sciences UFSCar/UNESP, Rod. Washington Luís, Km 235, São Carlos, SP 13565-905
dc.format.extent76-85
dc.identifierhttp://dx.doi.org/10.1016/j.bbr.2013.02.035
dc.identifier.citationBehavioural Brain Research, v. 246, p. 76-85.
dc.identifier.doi10.1016/j.bbr.2013.02.035
dc.identifier.issn0166-4328
dc.identifier.issn1872-7549
dc.identifier.scopus2-s2.0-84875584228
dc.identifier.urihttp://hdl.handle.net/11449/75505
dc.identifier.wosWOS:000318668100011
dc.language.isoeng
dc.relation.ispartofBehavioural Brain Research
dc.relation.ispartofjcr3.173
dc.relation.ispartofsjr1,413
dc.rights.accessRightsAcesso restritopt
dc.sourceScopus
dc.subjectAntidepressants
dc.subjectAnxiolytics and anxiogenics
dc.subjectDefensive behaviour
dc.subjectFactor analysis
dc.subjectMice
dc.subjectOpen elevated plus-maze
dc.subject(3 chlorophenyl)piperazine
dc.subjectalprazolam
dc.subjectdiazepam
dc.subjectfluoxetine
dc.subjectimipramine
dc.subjectpentetrazole
dc.subjectyohimbine
dc.subjectanimal behavior
dc.subjectanimal experiment
dc.subjectarm movement
dc.subjectbehavior change
dc.subjectbody posture
dc.subjectchronic drug administration
dc.subjectcontrolled study
dc.subjectdefensive behavior
dc.subjectdrug sensitivity
dc.subjectemotion
dc.subjectendocrine function
dc.subjectethnopharmacology
dc.subjectexploratory behavior
dc.subjecthead movement
dc.subjectmale
dc.subjectmaze test
dc.subjectmouse
dc.subjectnociception
dc.subjectnonhuman
dc.subjectopen elevated plus maze
dc.subjectpriority journal
dc.subjectrisk assessment
dc.titleEthopharmacological analysis of the open elevated plus-maze in miceen
dc.typeArtigopt
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dspace.entity.typePublication
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.author.orcid0000-0003-3818-0986[3]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.departmentPrincípios Ativos Naturais e Toxicologia - FCFpt

Arquivos